معرفی
Anders Olsson is a researcher at Linköping University, affiliated with the Department of Health, Medicine and Care (HMV) and the Department of Diagnostics and Specialist Medicine (DISP). He contributes to cardiovascular research with a focus on lipid metabolism and preventive cardiology.
- Active in clinical research on cardiovascular disease and diabetes
- Published extensively on lipoprotein dynamics and treatment outcomes
- Collaborates with international teams in large-scale clinical trials
His research examines the role of triglyceride-rich lipoproteins in atherosclerosis and evaluates novel therapies like PCSK9 inhibitors for mortality reduction. He also contributes to methodological advancements in medical imaging and AI applications for healthcare.
Anders Olsson's work intersects with projects such as EPSOMiP (fatty liver and cardiovascular disease) and SCAPIS (cardiovascular imaging). He is part of interdisciplinary networks like CESAR (cardiovascular research collaboration).
Contact: anders.olsson@liu.se
